Evidence map›Paper›PMID 35046414›Full record

ArticleNature communications2022

Advances in mixed cell deconvolution enable quantification of cell types in spatial transcriptomic data.

Patrick Danaher, Youngmi Kim, Brenn Nelson, Maddy Griswold, Zhi Yang, Erin Piazza, Joseph M Beechem

Abstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 191 papers.

0numbers the graph read from it
0cells of the map it votes in
191citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

191 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

131 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Patrick Danaher *NanoString Technologies, Seattle, WA, USA. pdanaher@nanostring.com.ORCID http://orcid.org/0000-0002-2844-5883
Youngmi Kim *NanoString Technologies, Seattle, WA, USA.
Brenn NelsonNanoString Technologies, Seattle, WA, USA.
Maddy GriswoldNanoString Technologies, Seattle, WA, USA.
Zhi YangNanoString Technologies, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-6577-8943
Erin PiazzaNanoString Technologies, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-3263-5946
Joseph M BeechemNanoString Technologies, Seattle, WA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mapping cell types across a tissue is a central concern of spatial biology, but cell type abundance is difficult to extract from spatial gene expression data. We introduce SpatialDecon, an algorithm for quantifying cell populations defined by single cell sequencing within the regions of spatial gene expression studies. SpatialDecon incorporates several advancements in gene expression deconvolution. We propose an algorithm harnessing log-normal regression and modelling background, outperforming classical least-squares methods. We compile cell profile matrices for 75 tissue types. We identify genes whose minimal expression by cancer cells makes them suitable for immune deconvolution in tumors. Using lung tumors, we create a dataset for benchmarking deconvolution methods against marker proteins. SpatialDecon is a simple and flexible tool for mapping cell types in spatial gene expression studies. It obtains cell abundance estimates that are spatially resolved, granular, and paired with highly multiplexed gene expression data.

Indexed as

AlgorithmsCell Line, TumorCellsHEK293 CellsHumansLeast-Squares AnalysisNeoplasmsRegression AnalysisTranscriptomeTumor Microenvironment

Identifiers

PMID35046414
PMCPMC8770643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.